cemsidomide
CFT7455-1101
Phase 2 small_molecule active
Quick answer
cemsidomide for Multiple Myeloma is a Phase 2 program (small_molecule) at C4 Therapeutics with 2 ClinicalTrials.gov record(s).
Program details
- Company
- C4 Therapeutics
- Indication
- Multiple Myeloma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active